http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200626587-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aeeae3a1e9c2f6b4db133adad89691b1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
filingDate 2005-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2be6efc49770f8a560f739f8dbf69509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c67770427155c9f65250890d69666b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e785dab6e02d23dcfb53736ed4fc5c0c
publicationDate 2006-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-200626587-A
titleOfInvention (Arylamidoanilino) nitroethylene compounds
abstract Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein A, Q, Y, R1, R2, and R5 are defined herein, are useful in the treatment of tumors and cancers such as mastocytosis/mast cell leukemia, gastrointestinal stromal tumors (GIST), germ cell tumors, small cell lung carcinoma (SCLC), sinonasal natural killer/T-cell lymphoma, testicular cancer (seminoma), thyroid carcinoma, malignant melanoma, ovarian carcinoma, adenoid cystic carcinoma, acute myelogenous leukemia (AML), breast carcinoma, pediatric T-cell acute lymphoblastic leukemia, neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma.
priorityDate 2004-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407027841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77197

Total number of triples: 16.